Unknown PHASE2 INTERVENTIONAL 1-arm NCT04275687

Thoracic Re-irradiation For Locoregionally Recurrent Non-small Cell Lung Cancer

Thoracic Re-irradiation For Locoregionally Recurrent Non-small Cell Lung Cancer Using Hypofractionated Technique.

Sponsor: Sun Yat-sen University

Conditions Loco-regionally Recurrent NSCLC After Thoracic Radiotherapy

Interventions Concurrent chemotherapy thoracic irradiation

Updated 5 times since 2020 Last updated: Feb 19, 2020 Started: Mar 1, 2020 Primary completion: Feb 1, 2025 Completion: Feb 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Loco-regionally Recurrent NSCLC After Thoracic Radiotherapy and is currently ongoing. Sun Yat-sen University leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Mar 2025 — Present [monthly]

Unknown PHASE2

Status: Recruiting → Unknown
Sep 2024 — Mar 2025 [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Jan 2021 — Jul 2024 [monthly]

Recruiting PHASE2
Mar 2020 — Jan 2021 [monthly]

Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sun Yat-sen University

Data source: Sun Yat-sen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China